Patent · US Active

Organ preconditioning formulation with mitochondrial elongating agents

US11344025B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 26, 2018
Grant dateMay 31, 2022
Priority date—
Expiry dateJun 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/95
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein is a formulation to pre-treat an organ prior to transplantation and for inducing mitochondrial morphological alterations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.